Elicio Therapeutics, Inc. (ELTX) financial statements and ratios from SEC XBRL: revenue $2.30M (TTM), net margin -1686.5%, revenue growth 7.6% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $2.30M |
| Net Margin | -1686.5% |
| Revenue Growth (YoY) | 7.6% |
| EPS Growth (YoY) | -56.8% |
| FCF Growth (YoY) | 6.3% |
| Price / Book | 10.03 |
| Price / Sales | 122.33 |
| FCF Yield | -37.9% |
| Sector P/E (Healthcare) | 21.7 |
ELTX overview · ELTX earnings · ELTX KPIs · ELTX investor relations · ELTX ownership · ELTX peers · ELTX filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.